These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24626869)

  • 1. Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations.
    Farizo KM; Burns DL; Finn TM; Gruber MF; Pratt RD
    J Infect Dis; 2014 Apr; 209 Suppl 1():S28-31. PubMed ID: 24626869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible options for new pertussis vaccines.
    Meade BD; Plotkin SA; Locht C
    J Infect Dis; 2014 Apr; 209 Suppl 1():S24-7. PubMed ID: 24626868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing pertussis epidemiology: everything old is new again.
    Clark TA
    J Infect Dis; 2014 Apr; 209(7):978-81. PubMed ID: 24626532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Licensed pertussis vaccines in the United States. History and current state.
    Klein NP
    Hum Vaccin Immunother; 2014; 10(9):2684-90. PubMed ID: 25483496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge.
    Burns DL; Meade BD; Messionnier NE
    J Infect Dis; 2014 Apr; 209 Suppl 1():S32-5. PubMed ID: 24626870
    [No Abstract]   [Full Text] [Related]  

  • 6. Pertussis: pertussis control strategies and the options for improving current vaccines.
    Plotkin SA
    Expert Rev Vaccines; 2014 Sep; 13(9):1071-2. PubMed ID: 25090359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of improved vaccines against whooping cough: current status.
    Marzouqi I; Richmond P; Fry S; Wetherall J; Mukkur T
    Hum Vaccin; 2010 Jul; 6(7):543-53. PubMed ID: 20448470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertussis control: time for something new?
    Clark TA; Messonnier NE; Hadler SC
    Trends Microbiol; 2012 May; 20(5):211-3. PubMed ID: 22494804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-emergence of pertussis: what are the solutions?
    Libster R; Edwards KM
    Expert Rev Vaccines; 2012 Nov; 11(11):1331-46. PubMed ID: 23249233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acellular pertussis vaccines: what lies ahead?
    Wiedermann BL
    Contemp Pediatr; 1995 Sep; 12(9):25-8, 30, 32 passim. PubMed ID: 10155576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resurgence of pertussis calls for re-evaluation of pertussis animal models.
    van der Ark AA; Hozbor DF; Boog CJ; Metz B; van den Dobbelsteen GP; van Els CA
    Expert Rev Vaccines; 2012 Sep; 11(9):1121-37. PubMed ID: 23151168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pertussis vaccine. Reemergence of the disease and new vaccination strategies].
    Moraga-Llop FA; Campins-Martí M
    Enferm Infecc Microbiol Clin; 2015 Mar; 33(3):190-6. PubMed ID: 25707329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonhuman primate and human challenge models of pertussis.
    Merkel TJ; Halperin SA
    J Infect Dis; 2014 Apr; 209 Suppl 1(Suppl 1):S20-3. PubMed ID: 24626867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health. The pertussis paradox.
    Allen A
    Science; 2013 Aug; 341(6145):454-5. PubMed ID: 23908204
    [No Abstract]   [Full Text] [Related]  

  • 16. Modelling the effect of changes in vaccine effectiveness and transmission contact rates on pertussis epidemiology.
    Pesco P; Bergero P; Fabricius G; Hozbor D
    Epidemics; 2014 Jun; 7():13-21. PubMed ID: 24928665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
    Wilson TR
    J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The United States research strategy on pertussis.
    La Montagne JR
    Dev Biol Stand; 1997; 89():25-8. PubMed ID: 9272332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracking Pertussis and Evaluating Control Measures through Enhanced Pertussis Surveillance, Emerging Infections Program, United States.
    Skoff TH; Baumbach J; Cieslak PR
    Emerg Infect Dis; 2015 Sep; 21(9):1568-73. PubMed ID: 26291475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
    Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
    N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.